High materiality8/10
Eli Lilly price target raised to $1,425 from $1,250 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
LLY received an analyst target update from UBS.
- UBS raises LLY target to $1,425 from $1,250.
Key facts
- 01
Target: $1,425
- 02
Posted price: $1,190
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.